It means monocytes are enriched using CD14-targeted immunomagnetic capture, resulting in a CD14-focused population that is typically favored when you need clearer gating and stronger CD14 identity for consistent downstream differentiation or immunophenotyping.
This product lists 90% purity, determined by flow cytometry. That gives you a measurable benchmark for planning assay sensitivity and interpreting donor-to-donor variation.
Yes. CD14+ monocytes are positioned as readily available precursors for generating macrophages and dendritic cells, and this product is described as offering high viability and plating efficiency, which are exactly the parameters most labs care about at differentiation Day 0.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.